[1]
A. K. Pandurangan, “Targeting IL-17A: A New Frontier in the Treatment of Colitis-Associated Cancer”, CURR CANCER RES, vol. 1, no. 1, pp. 16–24, Oct. 2025, doi: 10.64229/2ew2fm31.